Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE



Provided by: Medscape

Should the FDA Approve the Mediterranean Diet for Depression?

Published: Thu, 22 Feb 2018 12:37:36 EST
Two studies show impressive improvements in depression scores with a healthy diet high in plant-based foods and omega-3 fats.
Medscape Psychiatry

Lower-Dose Combo Immunotherapy Promising for Advanced Melanoma

Published: Thu, 22 Feb 2018 12:26:38 EST
Dr Jeffrey S. Weber reviews data from an open-label phase 1/2 trial assessing the efficacy and safety of combination pembrolizumab and reduced-dose ipilimumab in patients with advanced melanoma.
Medscape Oncology

'Moving the Needle' in Oncology Workforce Diversity

Published: Thu, 22 Feb 2018 12:04:36 EST
Authors of a recent ASCO statement on diversity discuss their experiences and suggestions for improving inclusivity in the oncology workforce.
Medscape Oncology

Hormone Therapy May Improve Schizophrenia Outcomes

Published: Thu, 22 Feb 2018 11:58:57 EST
A selective estrogen receptor modulator improves outcomes in men and women with schizophrenia when added to treatment with an antipsychotic.
Medscape Medical News
Displaying results 17-20 (of 20)
 1 - 2 - 3 - 4 - 5 


Roche pens $1.9B deal to buy oncology data firm Flatiron

Published: Fri, 16 Feb 2018 09:22:40 +0000
Roche has struck a $1.9 billion deal to acquire Flatiron Health. The takeover gives Roche ownership of the cancer software and real-world evidence that turned GV-backed Flatiron into a rising star.

Using stem cells to generate an immune attack against cancer

Published: Thu, 15 Feb 2018 18:37:05 +0000
Induced pluripotent stem cells have the power to transform into any cell in the body, making them a prime candidate for regenerative medicine. Scientists at Stanford University believe stem cells can also teach the immune system to recognize and attack cancer—and they tested the concept in mouse models of breast cancer.

Celgene spinoff debuts with big names, big bucks and big hopes

Published: Thu, 15 Feb 2018 15:31:12 +0000
A Celgene spinout known as Celularity with some of the biggest names across biotech and Silicon Valley has raised an eye-watering $250 million for its work in cancer.

Vertex’s big week continues as nonopioid pain drug clears second phase 2 test

Published: Thu, 15 Feb 2018 14:23:40 +0000
Vertex Pharma now has a pair of studies backing up its new drug VX-150, suggesting it can provide opioidlike pain relief without the addiction risks.
Displaying results 17-20 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy